CRIS Current Research Information System

BIFFI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.764
AS - Asia 10.641
EU - Europa 9.309
AF - Africa 597
SA - Sud America 570
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 6
Totale 32.906
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.669
VN - Vietnam 3.569
SG - Singapore 2.775
GB - Regno Unito 2.438
CN - Cina 2.298
IT - Italia 1.870
DE - Germania 1.251
UA - Ucraina 819
HK - Hong Kong 717
FR - Francia 697
SE - Svezia 607
RU - Federazione Russa 536
IN - India 529
BR - Brasile 402
IE - Irlanda 293
EE - Estonia 215
JP - Giappone 194
CI - Costa d'Avorio 180
ZA - Sudafrica 179
NL - Olanda 173
FI - Finlandia 145
KR - Corea 95
TG - Togo 83
SC - Seychelles 77
AR - Argentina 74
PH - Filippine 62
BD - Bangladesh 55
CA - Canada 51
BG - Bulgaria 46
JO - Giordania 45
CH - Svizzera 39
IQ - Iraq 39
TH - Thailandia 39
IR - Iran 31
AT - Austria 30
ID - Indonesia 28
MX - Messico 28
NG - Nigeria 28
BE - Belgio 26
TW - Taiwan 26
PL - Polonia 23
TR - Turchia 23
CL - Cile 22
PK - Pakistan 21
EC - Ecuador 20
SA - Arabia Saudita 20
CO - Colombia 19
ES - Italia 17
AU - Australia 15
EG - Egitto 15
GR - Grecia 15
UZ - Uzbekistan 15
PY - Paraguay 13
RO - Romania 13
MY - Malesia 10
CZ - Repubblica Ceca 9
LB - Libano 9
LT - Lituania 8
MA - Marocco 8
UY - Uruguay 8
NP - Nepal 7
DZ - Algeria 6
HR - Croazia 6
AE - Emirati Arabi Uniti 5
OM - Oman 5
PE - Perù 5
SN - Senegal 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
EU - Europa 4
KE - Kenya 4
KZ - Kazakistan 4
LU - Lussemburgo 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
VE - Venezuela 4
AZ - Azerbaigian 3
DK - Danimarca 3
IL - Israele 3
JM - Giamaica 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
HN - Honduras 2
KG - Kirghizistan 2
MD - Moldavia 2
MT - Malta 2
NO - Norvegia 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
BZ - Belize 1
CY - Cipro 1
Totale 32.891
Salva come PNG Salva come JPEG
Città #
Southend 2.147
Singapore 1.896
Ashburn 1.215
Fairfield 1.166
San Jose 786
Ho Chi Minh City 734
Hong Kong 674
Chandler 661
Jacksonville 586
Wilmington 581
Hanoi 554
Woodbridge 530
Seattle 513
Princeton 512
Houston 510
Santa Clara 503
Dong Ket 457
Cambridge 419
Ann Arbor 318
Dublin 292
Boardman 286
Beijing 275
Lauterbourg 246
Padova 233
Westminster 232
Nanjing 215
Los Angeles 189
Abidjan 180
Tokyo 180
Milan 158
Hefei 157
Berlin 144
Helsinki 133
Shenyang 123
Saint Petersburg 122
Medford 115
Jinan 107
Buffalo 106
Rome 101
Bologna 97
Changsha 89
Mülheim 88
New York 88
San Diego 87
Da Nang 84
Lomé 83
Bremen 73
Haiphong 72
Mahé 72
Hebei 69
Turin 69
Frankfurt am Main 64
Nanchang 63
Dallas 59
Redondo Beach 57
Seoul 56
Guangzhou 55
Jiaxing 53
Des Moines 52
Zhengzhou 48
Tianjin 47
Munich 46
Olalla 44
Sofia 44
São Paulo 44
Amman 42
Council Bluffs 41
Shanghai 41
The Dalles 39
Yubileyny 38
Hangzhou 37
Chicago 36
Ningbo 36
Biên Hòa 35
Hải Dương 34
Naples 33
Bari 30
Verona 29
Dearborn 27
Taizhou 27
Abeokuta 26
Brussels 26
Norwalk 26
Falkenstein 25
Falls Church 25
Can Tho 24
Haikou 24
Mountain View 24
Ninh Bình 24
Lanzhou 23
Toronto 23
London 22
Phoenix 22
Thái Nguyên 22
Johannesburg 21
Quận Bình Thạnh 21
Brooklyn 20
Bắc Giang 20
Florence 20
Baghdad 19
Totale 21.041
Salva come PNG Salva come JPEG
Nome #
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.083
Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD) 327
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 286
Resynchronization for HemodYnamic Treatment for Heart Failure Management II (RHYTHM II) Investigators. A prospective randomized evaluation of VV delay optimization in CRT-D recipients:echocardiographic observations from the RHYTHM II ICD study. 258
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 246
Bridging the future of cardiac stimulation: physiologic or leadless pacing? 232
Atrial fibrillation: it is better to be alone than in bad company! 230
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 226
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care 221
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 216
AF burden is important - Fact or fiction? 214
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 207
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 204
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 203
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 200
Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study 198
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 197
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 196
Automatic verification of ventricular stimulation: fusion management algorithm 195
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 195
Acute changes in electromechanical parameters during different pacing configurations using a quadripolar left ventricular lead 194
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 193
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 192
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 189
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 189
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia 189
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 185
Atrial fibrillation ablation: beyond electro-mechanical matters 184
Holter ECG for pacemaker/defibrillator carriers: What is its role in the era of remote monitoring? 181
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 179
Automatic management of left ventricular stimulation: hints for technologic improvement. 179
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. 178
Implantation of cardioverter-defibrillator: Effects on shoulder function. 176
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 176
Evaluation of fusion beat detection with a new ventricular automatic capture algorithm in ICDs. 173
BLOCK HF: how far does it extend indications for cardiac resynchronization therapy? 173
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 173
Preoperative checklist to reduce the risk of cardiac implantable electronic device infections 173
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 172
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 172
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 171
Fibrillazione atriale e terapia di resincronizzazione cardiaca: quale strategia? 171
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 170
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 169
Outcomes with dronedarone in atrial fibrillation: What differences between real-world practice and trials? A meta-analysis and meta-regression analysis 169
The "Subtle" connection between development of cardiac implantable electrical device infection and survival after complete system removal: An observational prospective multicenter study 168
Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death. 166
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients 166
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset 165
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 165
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 165
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 165
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 165
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 165
A prospective randomized evaluation of VV delay optimization in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 164
Evaluation of the atrial evoked response for capture detection with high-polarization leads. 163
Automatic management of left ventricular pacing output: effectiveness of stimulation and device longevity. Proceedings XIII International symposium on Progress in Clinical Pacing 163
Predictors of long-term survival free from relapses after extraction of infected CIED. 163
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing 162
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 162
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 158
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 157
L'ottimizzazione degli intervalli AV e VV nei pazienti con device biventricolare: revisione della letteratura e contributo sperimentale 155
Atrial fibrillation and heart failure: does one epidemic feed he other? 155
Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity! 154
Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices 153
Cardiac resynchronization therapy: is systole all that matters? 153
Cardiac resynchronisation therapy: effect on diastolic function –Evaluation by radionuclide angiography 151
The QRS interval in patients treated with resynchronization therapy: which value 151
Cardiac resynchronization therapy : effects on left and right ventricular ejection fraction during exercise 150
Phrenic stimulation: a challenge for cardiac resynchronization therapy 149
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 149
Non-valvular atrial fibrillation: Potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants 148
Decrease in patient radiation exposure by a tantalum filter during electrophysiological procedures. 147
Less is more: Can we achieve cardiac resynchronization with 2 leads only? 147
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 147
Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy. 147
Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry. 146
Implantable electrical devices for prevention of sudden cardiac death: data on implant rates from a 'real world' regional registry. 145
Atrial fibrillation: Adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction. 145
Single versus dual-chamber ICDs : evaluation of rhythm discrimination QRS morphology. 142
Atrial fibrillation in patients with cardiac resynchronization therapy: Clinical management and outcome 142
Follow-up a lungo termine di pazienti con sincope valutati con tilt test 141
A plateau waveform shape allows a much higher patient shock energy tolerance 141
Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectives. 140
Is cardiac resynchronization therapy cost-effective? 140
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. 140
Role of drugs and devices in patients at risk of sudden cardiac death. 140
Expenditure and value for money: the challenge of implantable cardioverter defibrillators 139
Prevention of infections in cardiovascular implantable electronic devices beyond the antibiotic agent 139
Cardiac resynchronization therapy: Implant rates, temporal trends and relationships with heart failure epidemiology 139
Ventricular dyssynchrony at rest and during exercise assessed by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 138
Prediction of atrial fibrillation in patients with an implantable cardioverter-defibrillator and heart failure. 138
Meta-analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all-cause mortality and hospitalizations. 138
Peri-operative management of patients taking antithrombotic therapy: need for an integrated proactive approach. 138
Cardiac resynchronization therapy in heart failure. Doubts and certainties. 138
Long-term follow-up of patients with syncope evaluated by head-up tilt test. 138
Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death 137
Cardiac resynchronization therapy and VV interval optimization: which relationship between QRS width and the results of echo-guided VV interval optimization? 137
Clinical and therapeutic implications of troponin elevation in cardiac arrest 137
Totale 18.060
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.688 0 0 0 0 0 0 0 0 0 180 144 1.364
2021/20223.655 340 192 257 282 352 256 67 285 109 139 613 763
2022/20233.778 405 475 208 492 196 241 108 209 666 194 332 252
2023/20241.084 88 176 75 75 118 189 78 60 64 61 41 59
2024/20254.289 177 923 320 335 812 206 192 105 55 232 120 812
2025/20268.992 1.105 749 935 593 1.004 588 1.027 715 1.687 589 0 0
Totale 33.357